LUMIRADX LTD's ticker is and the CUSIP is G5709L117. A total of 25 filers reported holding LUMIRADX LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $172 | -70.3% | 20,000 | 0.0% | 0.00% | – |
| Q3 2023 | $580 | -3.0% | 20,000 | 0.0% | 0.00% | – |
| Q2 2023 | $598 | -74.5% | 20,000 | 0.0% | 0.00% | – |
| Q1 2023 | $2,346 | +98.8% | 20,000 | 0.0% | 0.00% | – |
| Q4 2022 | $1,180 | -41.0% | 20,000 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | -88.9% | 20,000 | 0.0% | 0.00% | – |
| Q2 2022 | $18,000 | +5.9% | 20,000 | 0.0% | 0.00% | – |
| Q1 2022 | $17,000 | -52.8% | 20,000 | 0.0% | 0.00% | – |
| Q4 2021 | $36,000 | +56.5% | 20,000 | 0.0% | 0.00% | – |
| Q3 2021 | $23,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVS HEALTH Corp | 5,352,106 | $72,789 | 0.03% |
| Ancora Advisors LLC | 15,470 | $9 | 0.00% |